Legal Representation
Attorney
Jeannine A Rittenhouse
USPTO Deadlines
Next Renewal Deadline
344 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-06-16)
Due Date
June 16, 2026
Grace Period Ends
December 16, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
23 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 16, 2025 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Nov 22, 2023 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Oct 12, 2022 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Jul 13, 2022 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Jun 16, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Jun 10, 2020 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Mar 31, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Mar 31, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Mar 11, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Feb 27, 2020 | CHPB | I | POST PUBLICATION AMENDMENT - ENTERED |
| Feb 26, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Feb 26, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Feb 26, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 20, 2020 | ALIE | A | ASSIGNED TO LIE |
| Feb 13, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Feb 13, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Aug 26, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Aug 26, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Aug 26, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Aug 24, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
| Jun 22, 2019 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Jun 21, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jun 11, 2019 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of neurological diseases and disorders, nephrotic diseases, endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases and disorders, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous state, gastrointestinal diseases, hepatic diseases and disorders, biliary diseases and disorders, renal disorders, cardiovascular and lipid-related diseases and disorders, inflammatory and autoimmune diseases and disorders; intravenous analgesics and antipyretics; medical gases for inhalation; bioengineered tissues for surgical implantation
Class 010
Medical apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes and accessories and parts thereof, namely, medical and therapeutic gas delivery systems comprised primarily of gas cylinders, valves, regulators, flow meters, delivery hoses and apparatus and instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patients; Therapeutic medical device and accessories and parts thereof for extracting blood from the body, separating blood, treating it extracorporally, and returning it to the body used for extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy, and cellular therapies; injection devices incorporating prefilled syringes containing injectable pharmaceuticals for manual injection
Class 040
Custom manufacturing of pharmaceuticals and active pharmaceutical ingredients
Class 041
educational services, namely, training in the fields of pharmaceutical dosing and training in the use and operation of medical devices used to administer nitric oxide to a patient and medical devices used to administer extracorporeal photopheresis to a patient; educational services, namely, providing classes, seminars, and workshops in the fields of pharmaceuticals and medical devices
Class 042
Scientific research services for medical purposes
Additional Information
Design Mark
The mark consists of a design of a stylized "S" in purple on the left, with a design of 5 vertical lines that vary in length across the middle of the "S", with the tallest in the middle and the shortest on the outside, in blue and purple fading from top to bottom. The stylized wording "SONORANT THERAPEUTICS" is stacked vertically on the right, in purple.
Color Claim
The color(s) blue and purple is/are claimed as a feature of the mark.
Classification
International Classes
005
010
040
041
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"